Entry_ID	SMILES	Target_RNA_sequence	Molecule_name	Molecule_ID	Target_RNA_name	Target_RNA_ID	pKd
740	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	Thiamine_mol	Target_lig_502	B.subtilis tenA TPP riboswitch	Target_76	4.30102999566398
1584	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	Ribostamycin	Target_lig_1273	Oligonucleotide 3	Target_282	4.04575749056068
118	CC1=CC2=C(C=C1)C(=CC(=N2)N)C	GAGCGUCACACCUUCGGGUGAAGUCGCUC	N,4-dimethylquinolin-2-amine	Target_lig_89	A-site 16S rRNA_E_coli (1)	Target_3	4.22184874961636
1174	CCN1C2=C(C=C(C=C2)/C=C/C3=[N+](C4=CC=CC=C4C=C3)C)C5=CC=CC=C51	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	Methylquinolinium 16	Target_lig_671	A10-RNA-WT QGRS in ADAM10 mRNA	Target_196	4.71669877129645
1846	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CGG/3'GGC) x1	Target_345	6.619788758288389
125	C1=CC(=NC=C1[N+](=O)[O-])NCCN	GAGCGUCACACCUUCGGGUGAAGUCGCUC	methylpyridine_der_5	Target_lig_96	A-site 16S rRNA_E_coli (1)	Target_3	2.0
1882	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CGG/3'GGC) x20	Target_349	6.67778070526608
1874	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CGG/3'GGC)x6	Target_347	6.44369749923271
2457	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	Tobramycin	Target_lig_540	TS mRNA Construct_4	Target_445	5.63978538670465
2101	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	Azithromycin	Target_lig_223	50S subunit	Target_100	8.42021640338319
139	CC1=C(C(=O)C2=CC=CC=C2N1)CN3CCCCCC3	GAGCGUCACACCUUCGGGUGAAGUCGCUC	3-(azepan-1-ylmethyl)-2-methylquinolin-4-ol	Target_lig_110	A-site 16S rRNA_E_coli (1)	Target_3	3.39685562737982
814	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	Tobramycin	Target_lig_540	Thymidylate synthase m-RNA	Target_63	5.692932049338701
1578	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	Tobramycin	Target_lig_540	Oligonucleotide 3	Target_282	5.09691001300806
269	c1c(ccc2Sc3ccccc3N(c12)CCCCCN1CCC[C@H](C1)CO)C(=O)C	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	hydroxymethyl_piperidinyl_pentyl	Target_lig_209	HIV-1 TAR RNA	Target_19	2.52287874528034
228	CC1=CC(=NC2=C1C=CC(=C2)N)N(C)C	GAGCGUCACACCUUCGGGUGAAGUCGCUC	quinolinediamine_trimethyl_der	Target_lig_170	A-site	Target_3	4.45593195564972
666	C1CC(CCC1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_9	Target_lig_426	16s_rRNA A SITE	Target_3	3.97881070093006
1771	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUUAGUAUAGCGAGGUUUAACUACACUCGUGCUGAGCC	Tobramycin	Target_lig_540	J6f16 RNA	Target_310	8.59345981956604
321	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Tobramycin	Target_lig_540	Bacterial ribosomal A-site	Target_3	7.0
744	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	riboflavin	Target_lig_70	B.subtilis tenA FMN riboswitch	Target_77	5.52287874528034
1729	N=[N+]=NCCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)cc(cc2)c1ccc(cc1)N1CCN(CC1)C	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	Compound1	Target_lig_965	Pre-miR-21	Target_227	4.74472749489669
1590	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	Tobramycin	Target_lig_540	Oligonucleotide 4	Target_283	5.09691001300806
129	CN(C)C1=NC2=CC=CC=C2C(=C1)N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	2-N,2-N-dimethylquinoline-2,4-diamine	Target_lig_100	A-site 16S rRNA_E_coli (1)	Target_3	4.22184874961636
897	c1ccc2c(c1)Sc1c(N2CCCN(C)C)cc(cc1)C(=O)C	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Phenothiazine 5	Target_lig_1253	Acetylpromazine TAR RNA	Target_19	4.12901118623943
1004	C1=CC=C(C=C1)N2C=C(C(=N2)C3=CC4=C(C=CC5=CC=CC=C54)OC3=O)C=C6C(=O)NC(=S)NC6=O	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	SL3 RNA_ligand16	Target_lig_619	SL3 RNA	Target_146	4.29242982390206
256	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	dimethylamino_propyl_phenothiazinyl_ethanone	Target_lig_197	HIV-1 TAR RNA	Target_19	3.568636235841009
2288	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	Lincomycin	Target_lig_1175	50S ribosome (CLINDAMYCIN)	Target_100	5.30102999566398
1893	C1CNCCC1N2C=NC(=C2N)C(=O)N	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	AIZA analog 8	Target_lig_1048	Fusibacterium ulcerans ZTP riboswitch	Target_352	5.06048074738138
210	CN1C2=C(C(=O)N(C1=O)C)NC=N2	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	Theophylline	Target_lig_154	TCT8-4 RNA Aptamer	Target_32	6.49485002168009
2187	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	Neomycin B	Target_lig_1251	HCV IRES Domain Iib	Target_408	5.53760200210104
1059	NC(=[NH2+])NCCC[C@H]([NH3+])C(=O)NC1=CC2=C(C=C1)C1C3=CC=C(NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])C=C3C2C2=C1C=CC(NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])=C2	AUCGAUUGAGAGGAUUUGAAUGACUGACAAAAUGCAAAGUUUAGCUUUAGCCCCAGUUGGCAACGCAGCUAACGCGUGGCCGAUGUUGUCGGCUGACGAGGAGCGGGCGCUGGCUGAAAAGCUGCAUUACCAUGGCGCACCUGCGGUUUGUUGUUCAUAUUGCUCGUAAUUAUGCGGGCUAUGGC	Triptycene 2	Target_lig_626	RpoH Ïƒ32mRNA factor	Target_158	5.82390874094432
925	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	CGCGCAGUCAGUAGCGCG	DOS	Target_lig_383	RNA_XXII	Target_139	3.0
1875	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CAG/3'GUC)x6	Target_348	5.16749108729376
953	N([C@@H](C(=O)N1[C@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@@H](NC(=O)c1c(nc2c(cc3c(c2)OCO3)c1)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cc1c(c2)OCO1	GGCCUUCCCACAAGGGAAGGCC	disulfide_der_6	Target_lig_568	HIV-1 FSS	Target_188	5.847711655616941
377	[C@H]1([C@@H]([C@H]([C@@H](C[C@H]1CO)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1OCCN)O)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Ether paromomycin derivative 4	Target_lig_302	Bacterial ribosomal A-site	Target_3	4.721246399047169
390	CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	Puromycin	Target_lig_312	50S A-site for puromycin	Target_100	3.3187587626244106
344	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCCC(C)(C)C)O[C@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Aminoglycoside derivative 21	Target_lig_270	Bacterial ribosomal A-site	Target_3	5.602059991327961
1740	CCN(CC)CCNC(=O)C1=CC2=C(N1)C=CC(=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)N	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	Compound3	Target_lig_969	r(GGGGCC)8	Target_183	4.79588001734408
146	N1(CCCCCCC1)CCN1C=NC=2N(C(NC(C12)=O)=O)C	GAGCGUCACACCUUCGGGUGAAGUCGCUC	7-(2-(azocan-1-yl)ethyl)-3-methyl-1H-purine-2,6(3H,7H)-dione	Target_lig_117	A-site 16S rRNA_E_coli (1)	Target_3	3.54821356447571
1306	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	CAGCAGCGGCGGCGGCAGUGG	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-4	Target_244	7.08092190762393
825	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	Tobramycin	Target_lig_540	Bcr-Abl m-RNA	Target_64	5.44369749923271
1387	NCC1OC(OC2C(Cn3nnc(c3)Cc3nc4c(o3)ccc(c4)NC(=O)Nc3ccccc3)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Neomycin_nucleobase_3f	Target_lig_756	Pre-miR-372	Target_266	4.85698519974591
915	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	CGCGCAGUGUAGCGCG	DOS	Target_lig_383	RNA_XX	Target_137	3.0
934	C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	D-guanosine	Target_lig_553	Spiegelmer L-A42d RNA (58 mer)	Target_142	5.318758762624411
600	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Neomycin B	Target_lig_1251	16s_rRNA A SITE	Target_3	5.82390874094432
1888	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CGG/3'GGC) x60	Target_351	6.85387196432176
1305	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	GGCGGCGGCAGUGGCGGCGG	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-z	Target_243	6.53165266958784
333	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@H]([C@H]1OCCNC1CCNCC1)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Aminoglycoside derivative 9	Target_lig_259	Bacterial ribosomal A-site	Target_3	7.0
158	CN1CCCN(CC1)CC2=COC3=C(C2=O)C=C(C=C3)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	6-chloro-3-((4-methyl-1,4-diazepan-1-yl)methyl)-4H-chromen-4-one	Target_lig_128	A-site 16S rRNA_E_coli (1)	Target_3	3.80687540164554
1765	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAGCC	Tobramycin	Target_lig_540	J6f1 RNA	Target_307	8.28819277095881
1304	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	GCGGCGGCGGAGGCA	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-1	Target_242	7.040958607678911
232	CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OCC=CC4=CC5=CC=CC=C5N=C4)C)C)NC(=O)O2)C	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	Cethromycin	Target_lig_174	U2609_Ecoli_ribosome	Target_99	8.88605664769316
1767	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUUAGUAUAGCUAGGUUUAGCUACACUCGUGCUGAGCC	Tobramycin	Target_lig_540	J6fd6 RNA	Target_308	6.829738284605041
1891	C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	AIZA analog 5	Target_lig_1046	Fusibacterium ulcerans ZTP riboswitch	Target_352	5.6382721639824105
2246	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	Tobramycin	Target_lig_540	human tyrosine sulfotransferase mRNA	Target_410	4.187086643357141
717	[C@@H]1(C[C@H]([C@H]2[C@@H]([C@@H]1C(=O)C)O[C@H]1[C@@]2(C(=O)[C@@H](C(=O)C1)C(=O)C)C)O)O	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Phenothiazine 9	Target_lig_481	RNA_Str_HIV-1 TAR	Target_19	2.40671393297954
1870	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CGG/3'GGC)x6	Target_347	6.721246399047169
1880	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CGG/3'GGC) x20	Target_349	7.01772876696043
2045	C1=CN=C(N=C1N)N	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	2,4-diaminopyrimidine	Target_lig_1122	ADENINE RIBOSWITCH	Target_69	3.0
899	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGGCUAGCACUCUGGUAUCACGGUACCUUUGUGCGCCC	Acetylpromazine	Target_lig_176	Coxsackie virus B3 RNA	Target_130	3.48148606012211
2349	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1cnc2c1cccc2)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Neamine_derivative_14	Target_lig_1201	16s_rRNA A SITE	Target_3	3.1758741660834504
1409	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)F)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	Neomycin-3c	Target_lig_764	Pre-miR-373	Target_267	4.47237009912866
1396	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Neomycin-3d	Target_lig_765	Pre-miR-372	Target_266	4.5686362358410095
284	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	Azithromycin	Target_lig_223	Ribosome (PTC)	Target_99	8.42021640338319
1879	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CAG/3'GUC)x6	Target_348	5.2839966563652006
1287	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	DB1246	Target_lig_716	G4C2 repeat G-quadruplex RNA	Target_232	6.387216143280259
900	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGGGUUGUACCCACCCC	Acetylpromazine	Target_lig_176	Polio virus loop B construct	Target_131	2.744727494896689
2142	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	Tobramycin	Target_lig_540	HCV IRES Domain IIId	Target_66	5.65757731917779
2153	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	Compd 42	Target_lig_1282	HCV IRES Domain IIId	Target_66	5.69897000433602
2198	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	Compd 42	Target_lig_1282	HCV IRES Domain Iib	Target_408	5.508638306165731
2247	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	Neomycin B	Target_lig_1251	human tyrosine sulfotransferase mRNA	Target_410	6.52287874528034
2107	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	Eryrthromycin	Target_lig_233	50S subunit	Target_100	8.11350927482752
213	CN1C2=C(C(=O)N(C1=O)C)NC(=O)N2	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	1,3-dimethyluric acid	Target_lig_157	TCT8-4 RNA Aptamer	Target_32	3.0
1773	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUUAGUAUAGCGAGGUUUAGUUACACUCGUGCUGAGCC	Tobramycin	Target_lig_540	J6f17 RNA	Target_311	7.744727494896691
2171	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GAAGACAGCCGCUUCUACGAGCAU	Tobramycin	Target_lig_540	E. coli transglycosidase mRNA	Target_407	4.721246399047169
1350	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Cl)C4=C2C=CC(=C4)Cl)O	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Carbazole_analog_23	Target_lig_745	miR-21 hairpin	Target_265	5.49485002168009
792	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	Tobramycin	Target_lig_540	T box antiterminator RNA	Target_112	4.420216403383191
1252	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)[C@@H]([NH3+])CC2=CNC=N2)=CC=C1	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	S-Amino acid conjugate 3b	Target_lig_699	HIV-1 TAR	Target_19	4.75696195131371
274	c1cccc2Sc3ccc(cc3N(c12)CCN1CCCC1)Cl	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	2-chloro-10-methylpyrrolidin_phenothiazine_der	Target_lig_214	HIV-1 TAR RNA	Target_19	2.30102999566398
658	C1C[C@@H](C[C@@H]1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_1	Target_lig_420	16s_rRNA A SITE	Target_3	3.3010299956639804
2447	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	Tobramycin	Target_lig_540	G21A,A22G SLI_mutant	Target_444	7.15490195998574
1386	NCC1OC(OC2C(Cn3nnc(c3)CCCC(=O)Nc3cccc(c3)c3ncc(s3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Neomycin_nucleobase_3e	Target_lig_755	Pre-miR-372	Target_266	4.79588001734408
1260	CCOC(=O)C1=CC=CC=C1NC(=O)N2CCCN(CC2)CC3=CSC(=N3)C	CGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGCGGAAACGCUGAUGUCGUAUACAGGGCU	Compound 43 (MTDB)	Target_lig_706	SARS-Pseudoknot Construct	Target_218	3.67778070526608
2466	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CCCCCGCCACCUUCGGGUGGCCGGGG	Tobramycin	Target_lig_540	TS mRNA Construct_5	Target_446	5.4778166823813095
939	C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	D-Cytidine	Target_lig_558	Spiegelmer L-A42d RNA (58 mer)	Target_142	2.20760831050175
1885	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CGG/3'GGC) x40	Target_350	6.721246399047169
1769	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUUAGUAUAGCGAGGUUUGGCUACACUCGUGCUGAGCC	Tobramycin	Target_lig_540	J6f15 RNA	Target_309	7.744727494896691
1410	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	Neomycin-3d	Target_lig_765	Pre-miR-373	Target_267	4.32330639037513
2356	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1nc2c(n1)cccn2)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Neamine_derivative_28	Target_lig_1208	16s_rRNA A SITE	Target_3	3.25649023527157
805	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	Tobramycin	Target_lig_540	SLI of Rep A	Target_127	7.397940008672039
1886	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CGG/3'GGC) x60	Target_351	7.14874165128092
1596	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	Ribostamycin	Target_lig_1273	Oligonucleotide 4	Target_283	4.10790539730952
197	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	Tobramycin	Target_lig_540	decoding region 16SrRNA	Target_97	5.77211329538633
372	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCC[C@H]1NCCCC1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Perazidoparomomycin derivative 27	Target_lig_298	Bacterial ribosomal A-site	Target_3	5.44369749923271
1911	CC1=CC(=CC=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=C(ON=C5C)C	UGUGGGAGGGGCGGGUCUGGG	NRAS SAR 14	Target_lig_1061	NRAS G4 motif	Target_259	6.55284196865778
607	[C@H]1([C@@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@@H]([C@@H](C[C@@H]1N)N)O)OCC(=O)NCCCCCNC(=O)CO[C@@H]1[C@@H]([C@H](C[C@@H]([C@H]1O)N)N)O[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)CN)O)O)N)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Bifunctional_aminoglycoside_derivative_1	Target_lig_353	16s_rRNA A SITE	Target_3	6.096910013008059
2216	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	Tobramycin	Target_lig_540	HIV protease active site (PAS) mRNA	Target_409	4.85387196432176
2046	Nc1nc(N)nc(n1)N	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	2,4,6-triamino-1,3,5-triazine	Target_lig_1123	ADENINE RIBOSWITCH	Target_69	4.69897000433602
1395	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)F)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Neomycin-3c	Target_lig_764	Pre-miR-372	Target_266	4.64781748188864
1922	C1CN(CCC1N2CCC(CC2)O)C3=NC=NC(=C3)CCN	UGUGGGAGGGGCGGGUCUGGG	Hit S5	Target_lig_1071	NRAS G4 motif	Target_259	4.4089353929735
1868	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CAG/3'GUC) x1	Target_346	5.267606240177031
2172	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	GAAGACAGCCGCUUCUACGAGCAU	Neomycin B	Target_lig_1251	E. coli transglycosidase mRNA	Target_407	5.55284196865778
634	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)OCN2C=CN=C2)O)O)N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Heterocyclic paromomycin derivative 2	Target_lig_380	16s_rRNA A SITE	Target_3	3.56066730616974
123	CC1=CC(=NC=C1)NCCCN	GAGCGUCACACCUUCGGGUGAAGUCGCUC	methylpyridine_der_3	Target_lig_94	A-site 16S rRNA_E_coli (1)	Target_3	4.69897000433602
637	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Quinolinyl_DOS_der	Target_lig_383	16s_rRNA A SITE	Target_3	4.16749108729376
2217	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	Neomycin B	Target_lig_1251	HIV protease active site (PAS) mRNA	Target_409	5.69897000433602
1924	CC(CCC1=CC=CO1)NC2CCC3(CC2)CCNCC3	UGUGGGAGGGGCGGGUCUGGG	Hit S7	Target_lig_1073	NRAS G4 motif	Target_259	4.01772876696043
1505	O=c1n2Cc3nc4scc(c4c(=O)n3Cc2nc2c1c(cs2)c1ccoc1)c1ccco1	AGGGUUAGGGUUAGGGUUAGGG	RGB-1	Target_lig_815	TERRA G-quadruplex	Target_255	5.229147988357861
2186	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	Tobramycin	Target_lig_540	HCV IRES Domain Iib	Target_408	5.5686362358410095
2228	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	Compd 42	Target_lig_1282	HIV protease active site (PAS) mRNA	Target_409	5.15490195998574
2500	O=C(Nc1ccc(cc1)C(=O)C)OCC1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	Compound (4S,5R)-2	Target_lig_1242	Antiterminator model RNA AM1A	Target_147	5.79588001734408
235	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Acetylpromazine	Target_lig_176	HIV-1 TAR RNA	Target_19	3.568636235841009
1307	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	CCGCCGCAGUGGCGGCGG	Anthrathiophenedione 2b	Target_lig_720	RNA Hairpin	Target_245	6.31695296176115
1883	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CGG/3'GGC) x40	Target_350	7.05551732784983
2438	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	Tobramycin	Target_lig_540	C19U,G20A SLI_mutant	Target_443	7.221848749616361
310	CC1C(C(CC(O1)OC2C(OC3(CC2O)OC4C(OC(C(C4(O3)C)O)OC5C(C(OC(C5OC)C)OC6C(OC(C(C6O)OC)OC7C(C8C(CO7)OC9(O8)C1C(C(CO9)OC(=O)C2=C(C=C(C=C2C)O)O)OCO1)O)COC)O)C)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])OC(=O)C1=C(C(=C(C(=C1OC)Cl)O)Cl)C	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	Evernimicin	Target_lig_247	Bacterial 23S rRNA hairpins 82 and 91	Target_102	4.52287874528034
2420	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	Tobramycin	Target_lig_540	U15C,U16C SLI_mutant	Target_441	7.045757490560679
2393	CN(c1ncnc2c1n(CCn1cnc3c1ncnc3N(C)C)cn2)C	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	SL3_compound_2	Target_lig_1234	SL-3 of HIV-1_SITE	Target_146	4.49485002168009
1856	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	B11	Target_lig_1042	(5'CGG/3'GGC) x1	Target_345	6.44369749923271
1858	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	B1	Target_lig_716	(5'CAG/3'GUC) x1	Target_346	5.44369749923271
920	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	CGCGCAGUAGUAGCGCG	DOS	Target_lig_383	RNA_XXI	Target_138	3.0
718	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Phenothiazine 10	Target_lig_482	RNA_Str_HIV-1 TAR	Target_19	2.00921730819686
625	[C@@H]1([C@H]([C@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@H]([C@@H](O[C@H]1CN)OC)N)O)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Neamine mimic_5	Target_lig_371	16s_rRNA A SITE	Target_3	4.958607314841769
366	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CN1C[C@H]2[C@H](C1)CCCC2)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Perazidoparomomycin derivative 19	Target_lig_292	Bacterial ribosomal A-site	Target_3	1.88941028970075
295	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	Eryrthromycin	Target_lig_233	PTC	Target_99	6.00436480540245
840	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	Tobramycin	Target_lig_540	PAX3-FKHR m-RNA	Target_65	5.744727494896691
1607	CN1CCN(CC1)c1cc(F)c2c(c1)oc(=O)c(c2)c1cccc(c1)Cl	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	SMN2_compound_6	Target_lig_864	SMN2 pre-mRNA GA-rich sequence	Target_284	4.484126156288321
2429	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	Tobramycin	Target_lig_540	G17A,G18A SLI_mutant	Target_442	7.52287874528034
2257	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	Compd 42	Target_lig_1282	human tyrosine sulfotransferase mRNA	Target_410	5.4089353929735005
849	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	Tobramycin	Target_lig_540	RRE-RNA	Target_80	5.52287874528034
136	CC1=CC=CC=C1OCCNC2=C(C=CC(=C2)N3CCNCC3)[N+](=O)[O-]	GAGCGUCACACCUUCGGGUGAAGUCGCUC	2-nitro-5-(piperazin-1-yl)-N-(2-(o-tolyloxy)ethyl)aniline	Target_lig_107	A-site 16S rRNA_E_coli (1)	Target_3	3.6903698325741
942	CN1C2=C(C(=O)N(C1=O)C)NC=N2	GGUGAUACCAGCCGAAAGGCCCUUGGCAGCACC	Theophylline	Target_lig_154	T alpha aptamer	Target_60	6.82390874094432
910	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	CGCGCGUGUGCGCG	DOS	Target_lig_383	RNA_XIX	Target_136	3.0
752	C1CN(CCN1C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3)C4=CC=CC=C4	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	phenylacetate derivative	Target_lig_510	T-box riboswitch	Target_79	5.18045606445813
2048	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGGGUUGUACCCACCCCAC	Acetylpromazine	Target_lig_176	Polio virus loop B RNA	Target_374	2.744727494896689
670	COC1=CC2=C(C=C1)N=C(N2)C3CCNCC3	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_13	Target_lig_430	16s_rRNA A SITE	Target_3	3.23062267392386
898	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Acetylpromazine	Target_lig_176	A-site bindings	Target_3	3.44369749923271
2183	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	GAAGACAGCCGCUUCUACGAGCAU	Compd 42	Target_lig_1282	E. coli transglycosidase mRNA	Target_407	5.602059991327961
2389	NCCCNC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(NC(=O)c1cc2ccccc2nc1CC)C/C=C/C[C@@H](C(=O)N1CCCC1C(=O)NC(C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cc2ccccc2nc1CC	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	Dicarba_derivative_9	Target_lig_1230	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Target_109	6.481486060122111
1795	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CC(=O)N)CCC	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	miR-21 binder compound 2	Target_lig_1009	miR-21	Target_227	6.008773924307509
2143	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	Neomycin B	Target_lig_1251	HCV IRES Domain IIId	Target_66	5.53760200210104
2047	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	GGGCUAGCACUCUGGUAUCACGGUACCUUUGUGCGCCC	Acetylpromazine	Target_lig_176	CVB loop D RNA	Target_373	3.48148606012211
956	N([C@H](C(=O)N1[C@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C/C=C/C[C@H](NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cccc2	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	dicarba_analog_1	Target_lig_571	HIV-1 genomic SL3 rna	Target_146	6.481486060122111
1079	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	2H-4	Target_lig_634	r(CGG)12	Target_169	6.67366413907125
96	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	GGAACGAGGGAUGGAGGAGGAGUCGUUCC	riboflavin	Target_lig_70	Riboflavin binding RNA aptamer	Target_29	-0.477121254719662
1336	OC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)CNc1ccc(cc1)N1CCOCC1	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Aniline_analog_7	Target_lig_731	miR-21 hairpin	Target_265	5.67778070526608
